vs
BICYCLE THERAPEUTICS PLC（BCYC）与TELOS CORP（TLS）财务数据对比。点击上方公司名可切换其他公司
BICYCLE THERAPEUTICS PLC的季度营收约是TELOS CORP的1.0倍（$48.0M vs $46.8M），TELOS CORP净利率更高（-34.9% vs -42.0%，领先7.2%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs 77.4%），TELOS CORP自由现金流更多（$8.0M vs $-19.9M），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs 25.7%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
泰洛斯公司（Telos Corporation）是一家信息技术与网络安全企业，总部位于美国弗吉尼亚州阿什本。公司主要服务对象为政府与企业客户，业务合同大部分来自美国国防部，核心客户涵盖美国军方、情报机构、民政部门以及北约盟友机构。
BCYC vs TLS — 直观对比
营收规模更大
BCYC
是对方的1.0倍
$46.8M
营收增速更快
BCYC
高出1115.9%
77.4%
净利率更高
TLS
高出7.2%
-42.0%
自由现金流更多
TLS
多$27.9M
$-19.9M
两年增速更快
BCYC
近两年复合增速
25.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $46.8M |
| 净利润 | $-20.2M | $-16.3M |
| 毛利率 | — | 35.0% |
| 营业利润率 | -51.5% | -39.6% |
| 净利率 | -42.0% | -34.9% |
| 营收同比 | 1193.3% | 77.4% |
| 净利润同比 | 61.1% | -74.8% |
| 每股收益（稀释后） | $-0.29 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCTLS
| Q4 25 | $48.0M | $46.8M | ||
| Q3 25 | $11.7M | $51.4M | ||
| Q2 25 | $2.9M | $36.0M | ||
| Q1 25 | $10.0M | $30.6M | ||
| Q4 24 | $3.7M | $26.4M | ||
| Q3 24 | $2.7M | $23.8M | ||
| Q2 24 | $9.4M | $28.5M | ||
| Q1 24 | $19.5M | $29.6M |
净利润BCYCTLS
| Q4 25 | $-20.2M | $-16.3M | ||
| Q3 25 | $-59.1M | $-2.1M | ||
| Q2 25 | $-79.0M | $-9.5M | ||
| Q1 25 | $-60.8M | $-8.6M | ||
| Q4 24 | — | $-9.3M | ||
| Q3 24 | $-50.8M | $-28.1M | ||
| Q2 24 | $-39.8M | $-7.8M | ||
| Q1 24 | $-26.6M | $-7.4M |
毛利率BCYCTLS
| Q4 25 | — | 35.0% | ||
| Q3 25 | — | 39.9% | ||
| Q2 25 | — | 33.2% | ||
| Q1 25 | — | 39.8% | ||
| Q4 24 | — | 40.3% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 34.1% | ||
| Q1 24 | — | 37.0% |
营业利润率BCYCTLS
| Q4 25 | -51.5% | -39.6% | ||
| Q3 25 | -558.6% | -4.8% | ||
| Q2 25 | -2965.8% | -27.5% | ||
| Q1 25 | -703.7% | -29.5% | ||
| Q4 24 | — | -37.6% | ||
| Q3 24 | -2385.9% | -121.4% | ||
| Q2 24 | -498.3% | -30.3% | ||
| Q1 24 | -162.4% | -28.5% |
净利率BCYCTLS
| Q4 25 | -42.0% | -34.9% | ||
| Q3 25 | -503.7% | -4.1% | ||
| Q2 25 | -2703.8% | -26.5% | ||
| Q1 25 | -608.9% | -28.1% | ||
| Q4 24 | — | -35.4% | ||
| Q3 24 | -1898.4% | -118.0% | ||
| Q2 24 | -425.3% | -27.2% | ||
| Q1 24 | -136.0% | -24.9% |
每股收益（稀释后）BCYCTLS
| Q4 25 | $-0.29 | $-0.22 | ||
| Q3 25 | $-0.85 | $-0.03 | ||
| Q2 25 | $-1.14 | $-0.13 | ||
| Q1 25 | $-0.88 | $-0.12 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.74 | $-0.39 | ||
| Q2 24 | $-0.77 | $-0.11 | ||
| Q1 24 | $-0.62 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $53.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $96.0M |
| 总资产 | $717.6M | $139.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCTLS
| Q4 25 | $628.1M | $53.2M | ||
| Q3 25 | $648.3M | $59.0M | ||
| Q2 25 | $721.5M | $57.0M | ||
| Q1 25 | $793.0M | $57.8M | ||
| Q4 24 | $879.5M | $54.6M | ||
| Q3 24 | $890.9M | $69.8M | ||
| Q2 24 | $961.4M | $80.1M | ||
| Q1 24 | $457.0M | $93.9M |
总债务BCYCTLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCTLS
| Q4 25 | $610.0M | $96.0M | ||
| Q3 25 | $618.5M | $119.7M | ||
| Q2 25 | $668.9M | $118.4M | ||
| Q1 25 | $740.3M | $126.1M | ||
| Q4 24 | $793.1M | $127.1M | ||
| Q3 24 | $831.0M | $129.5M | ||
| Q2 24 | $873.8M | $149.1M | ||
| Q1 24 | $356.0M | $154.4M |
总资产BCYCTLS
| Q4 25 | $717.6M | $139.9M | ||
| Q3 25 | $764.0M | $164.3M | ||
| Q2 25 | $832.2M | $165.0M | ||
| Q1 25 | $883.9M | $158.1M | ||
| Q4 24 | $956.9M | $158.2M | ||
| Q3 24 | $996.7M | $166.3M | ||
| Q2 24 | $1.1B | $182.4M | ||
| Q1 24 | $547.1M | $195.4M |
负债/权益比BCYCTLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $8.0M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $8.0M |
| 自由现金流率自由现金流/营收 | -41.5% | 17.0% |
| 资本支出强度资本支出/营收 | 1.2% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | $29.4M |
8季度趋势，按日历期对齐
经营现金流BCYCTLS
| Q4 25 | $-19.3M | $8.0M | ||
| Q3 25 | $-71.2M | $9.1M | ||
| Q2 25 | $-72.8M | $7.0M | ||
| Q1 25 | $-86.4M | $6.1M | ||
| Q4 24 | $-164.7M | $-10.5M | ||
| Q3 24 | $-39.8M | $-7.1M | ||
| Q2 24 | $-44.6M | $-8.0M | ||
| Q1 24 | $-70.9M | $-350.0K |
自由现金流BCYCTLS
| Q4 25 | $-19.9M | $8.0M | ||
| Q3 25 | $-71.8M | $8.7M | ||
| Q2 25 | $-73.3M | $6.8M | ||
| Q1 25 | $-87.0M | $6.0M | ||
| Q4 24 | $-166.0M | $-12.4M | ||
| Q3 24 | $-40.3M | $-7.1M | ||
| Q2 24 | $-45.0M | $-8.2M | ||
| Q1 24 | $-70.9M | $-447.0K |
自由现金流率BCYCTLS
| Q4 25 | -41.5% | 17.0% | ||
| Q3 25 | -612.3% | 16.9% | ||
| Q2 25 | -2509.7% | 19.0% | ||
| Q1 25 | -871.7% | 19.5% | ||
| Q4 24 | -4475.7% | -47.0% | ||
| Q3 24 | -1504.7% | -30.0% | ||
| Q2 24 | -481.2% | -28.9% | ||
| Q1 24 | -362.9% | -1.5% |
资本支出强度BCYCTLS
| Q4 25 | 1.2% | 0.1% | ||
| Q3 25 | 5.7% | 0.9% | ||
| Q2 25 | 17.1% | 0.4% | ||
| Q1 25 | 6.1% | 0.4% | ||
| Q4 24 | 33.3% | 7.1% | ||
| Q3 24 | 16.3% | 0.2% | ||
| Q2 24 | 4.5% | 0.8% | ||
| Q1 24 | 0.1% | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCYC
暂无分部数据
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
